Published in J Neuroimmunol on March 01, 1997
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology (2011) 1.81
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology (2010) 1.72
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler (2008) 1.70
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol (1989) 1.59
Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol (1992) 1.59
Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure. J Clin Endocrinol Metab (2001) 1.41
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med (1988) 1.40
Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues. Acta Neuropathol (1996) 1.39
Inflammatory aneurysm of the abdominal aorta. A prospective clinical study. J Cardiovasc Surg (Torino) (1999) 1.39
[Mutism after posterior fossa tumor surgery. Report of 2 cases]. Arq Neuropsiquiatr (1995) 1.37
Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res (2000) 1.35
Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology (2009) 1.35
Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology (2010) 1.27
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Mult Scler (2012) 1.26
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology (2010) 1.21
Artificial neural network algorithm for online glucose prediction from continuous glucose monitoring. Diabetes Technol Ther (2010) 1.16
Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci (2002) 1.15
Trade-offs in prenatal detection of Down syndrome. Am J Public Health (1998) 1.15
Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler (2009) 1.15
Electrode positioning for reliable telemetry ECG recordings during social stress in unrestrained rats. Physiol Behav (1996) 1.14
Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology (2011) 1.14
Plasma radio-frequency-based diskectomy for treatment of cervical herniated nucleus pulposus: feasibility, safety, and preliminary clinical results. AJNR Am J Neuroradiol (2006) 1.13
Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol (1997) 1.09
Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry (2011) 1.08
Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis (2000) 1.08
Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care (2006) 1.07
Customizing CellSearch platform. Cytometry A (2013) 1.07
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06
Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. J Immunol (1991) 1.06
The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol (1995) 1.06
Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol (1997) 1.06
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis. Mult Scler (2011) 1.05
A computerized data bank of surgical pathology and cytopathology diagnoses. Structure and purposes. Virchows Arch A Pathol Anat Histopathol (1983) 1.03
Cerebrospinal fluid electroimmunodiffusion. An easy, rapid, sensitive, reliable, and valid method for the simultaneous determination of immunoglobulin-G and albumin. Arch Neurol (1971) 1.03
Home palliative care as a cost-saving alternative: evidence from Catalonia. Palliat Med (2001) 1.02
Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid. J Neurol Sci (1989) 1.02
Case report of heterotopic bone formation in metastatic carcinoma of the colon. Tumori (1979) 1.01
Tumour necrosis factor-alpha in infectious meningitis. Arch Dis Child (1989) 1.01
Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med (2000) 1.01
Rheological and fibrinolytic findings in multiple sclerosis. J Neurol Neurosurg Psychiatry (1981) 1.00
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99
Immune infiltrates and cytokines in gliomas. Acta Neurochir (Wien) (1996) 0.98
Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol (1994) 0.98
Epidemiological survey on multiple sclerosis in Italy. Riv Patol Nerv Ment (1976) 0.95
Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol (1997) 0.95
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler (2008) 0.95
The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS (1999) 0.95
Angioplasty and stenting of the cervical carotid bifurcation under filter protection: a prospective study in a series of 53 patients. J Neuroradiol (2005) 0.94
The spectrum of antineuronal autoantibodies in a series of neurological patients. J Neurol Sci (2004) 0.93
Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int J Dev Neurosci (1995) 0.93
Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. Eur Cytokine Netw (2001) 0.92
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91
Model for single-particle dynamics in supercooled water. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.91
Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J Neurol Sci (1994) 0.90
Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ (2007) 0.90
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results. Neurol Sci (2007) 0.90
A route to explain water anomalies from results on an aqueous solution of salt. J Chem Phys (2010) 0.90
Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet (1998) 0.90
Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci (1990) 0.89
A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. Gene Ther (2007) 0.89
Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid. J Neuroimmunol (1990) 0.89
Aneurysm of the left renal vein: a case report. J Vasc Surg (1994) 0.89
Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol (1996) 0.88
Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol (1988) 0.88
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler (2008) 0.88
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult Scler (2005) 0.88
[The future of human pathology. Comparison of 2 samples of 1,000 consecutive autopsies performed in the years 1944 and 1974]. Recenti Prog Med (1976) 0.87
Free light chains in the CSF in multiple sclerosis. J Neurol (1987) 0.87
Tumor necrosis factor alpha (TNF alpha) and neurological diseases. Failure in detecting TNF alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours. J Neuroimmunol (1989) 0.87
Pathological findings of HIV-associated cardiovascular disease. Ann N Y Acad Sci (2001) 0.87
Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum (2003) 0.86
Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol (1989) 0.86
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. Mult Scler (2012) 0.86
Differential role for Sp1/Sp3 transcription factors in the regulation of the promoter activity of multiple cyclin-dependent kinase inhibitor genes. J Cell Biochem (2000) 0.86
Detection of Brucella species in buffalo whole blood by gene-specific PCR. Vet Rec (2000) 0.86
Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder. Int Urogynecol J (2013) 0.85
Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler (2003) 0.85
Is apoptosis a diagnostic marker of acute myocardial infarction? Arch Pathol Lab Med (2000) 0.85
DHPLC analysis of the MECP2 gene in Italian Rett patients. Hum Mutat (2001) 0.85
Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur J Neurol (2005) 0.85
The importance of symptom duration in relation to prognosis of carcinoma of the large intestine. Surg Gynecol Obstet (1984) 0.85
Oesophageal phlebectasis in an infant with pulmonary venous obstruction owing to a congenital heart defect. Z Kardiol (1976) 0.84
Cortical lesions and cognitive impairment in multiple sclerosis. Neurol Sci (2010) 0.84
X-linked adrenoleukodystrophy with olivopontocerebellar atrophy. Eur J Neurol (2005) 0.83
Maternally inherited cardiomyopathy: clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid. J Am Coll Cardiol (1999) 0.83
Fatal congenital myopathy and gastrointestinal pseudo-obstruction due to POLG1 mutations. Neurology (2009) 0.83
Levels and congener profiles of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like polychlorinated biphenyls in cow's milk collected in Campania, Italy. Chemosphere (2009) 0.83
Rupture of Dacron aorto-femoral graft. Case report. J Cardiovasc Surg (Torino) (1999) 0.82
[Echocardiography for the evaluation of tricuspid atresia. I. Morphological analysis (author's transl)]. G Ital Cardiol (1981) 0.82
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.82
Central nervous system involvement in HIV infection. AIDS Res Hum Retroviruses (1988) 0.82
1D and 2D arrays of coupled photonic crystal cavities with a site-controlled quantum wire light source. Opt Express (2013) 0.82